Skip to main content

Syndicate Bio

Syndicate Bio

Type

startup

Founded

2023

Funding captured

undisclosed

Deals captured

0

About Syndicate Bio

Syndicate Bio is a platform biotechnology company focused on genomics and precision medicine across genetically diverse regions with an initial market focus in Africa. The company builds large, ethically governed genomic datasets to support drug discovery and precision oncology, delivers clinical genetic testing services (including hereditary cancer screening, non-invasive prenatal testing, somatic tumor profiling and pharmacogenomics) through consumer- and provider-facing channels, forges partnerships with governments, research institutions and healthcare providers, and runs capacity-building programs to train local scientists in genomic and molecular techniques.